Reduction in endogenous parkin levels renders glial cells sensitive to both caspase-dependent and caspase-independent cell death

European Journal of Neuroscience

Volumn 20, Issue 8, 2004, Pages 2038-2048

  MacCormac, Luci P ^a   Muqit, Miratul M K ^a,b   Faulkes, David J ^a   Wood, Nicholas W ^b   Latchman, David S ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Glia; Parkin; Parkinson's disease; Rat

Indexed keywords

CASPASE; CASPASE INHIBITOR; DOPAMINE; DOXYCYCLINE; HYDROGEN PEROXIDE; LIGASE; PARKIN; STAUROSPORINE; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE JUVENILE PARKINSONISM; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME INHIBITION; FAMILIAL DISEASE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIA CELL; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

ANIMALS; CASPASES; CELL DEATH; CELL LINE; DOPAMINE; HUMANS; HYDROGEN PEROXIDE; NEUROGLIA; PROTEASE INHIBITORS; RATS; UBIQUITIN-PROTEIN LIGASES;

EID: 4944238558     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03659.x     Document Type: Article

References (59)

1. Alam, Z.I., Daniel, S.E., Lees, A.J., Marsden, C.D., Jenner, P. & Halliwell, B. (1997a) A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem., 69, 1326-1329.
2. Alam, Z.I., Jenner, A., Daniel, S.E., Lees, A.J., Cairns, N., Marsden, C.D., Jenner, P. & Halliwell, B. (1997b) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem., 69, 1196-1203.
3. Barzilai, A., Zilkha-Falb, R., Daily, D., Stern, N., Offen, D., Ziv, I., Melamed, E. & Shirvan, A. (2000) The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. J. Neural Transm., 60 (Suppl.), 59-76.
4. Bianchi, P., Seguelas, M.H., Parini, A. & Cambon, C. (2003) Activation of proapoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J. Am. Soc. Nephrol., 14, 855-862.
5. Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y. & Hirsch, E.C. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett., 172, 151-154.
6. Bolaños, J.P., Heales, S.J.R., Land, J.M. & Clark, J.B. (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem., 64, 1965-1972.
7. de Bono, D.P. & Yang, W.D. (1995) Exposure to low concentrations of hydrogen peroxide causes delayed endothelial cell death and inhibits proliferation of surviving cells. Atherosclerosis, 114, 235-245.
8. Chinopoulos, C. & Adam-Vizi, V. (2001) Mitochondria deficient in complex I activity are depolarized by hydrogen peroxide in nerve terminals: relevance to Parkinson's disease. J. Neurochem., 76, 302-306.
9. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. & Dawson, T.M. (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med., 7, 1144-1150.
10. Darios, F., Corti, O., Lucking, C.B., Hampe, C., Muriel, M.P., Abbas, N., Gu, W.J., Hirsch, E.C., Rooney, T., Ruberg, M. & Brice, A. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria- dependent cell death. Hum. Mol. Genet., 12, 517-526.
11. Dauer, W. & Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron, 39, 889-909.
12. Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P. & Marsden, C.D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem., 52, 381-389.
13. Dringen, R., Gutterer, J.M. & Hirrlinger, J. (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem., 267, 4912-4916.
14. Fahn, S. (2003) Description of Parkinson's disease as a clinical syndrome. Ann. NY Acad. Sci., 991, 1-14.
15. Fahn, S. & Cohen, G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol., 32, 804-812.
16. Gegg, M.E., Beltran, B., Salas-Pino, S., Bolanos, J.P., Clark, J.B., Moncada, S. & Heales, S.J. (2003) Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration? J. Neurochem., 86, 228-237.
17. Goldberg, M.S., Fleming, S.M., Palacino, J.J., Cepada, C., Lam, H.A., Bhatnagar, A., Meloni, E.G., Wu, N., Ackerson, L.C., Klapstein, G.J., Gajendiran, M., Roth, B.L., Chesselet, M.F., Maidment, N.T., Levine, M.S. & Shen, J. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem., 278, 43628-43635.
18. Greene, J.C., Whitworth, A.J., Leither, J.L., Andrews, L.A. & Pallank, L.J. (2003) Oxidative damage and cell cycle activation in Drosophila Parkin mutants. Soc. Neurosci. Abstr., 29, 132.7.
19. Hart, S.L., Arancibia-Carcamo, C.V., Wolfert, M.A., Mailhos, C., O'Reilly, N.J., Ali, R.R., Coutelle, C., George, A.J., Harbottle, R.P., Knight, A.M., Larkin, D.F., Levinsky, R.J., Seymour, L.W., Thrasher, A.J. & Kinnon, C. (1998) Lipid-mediated enhancement of transfection by a nonviral integrin-targeting vector. Hum. Gene Ther., 9, 575-585.
20. Hartmann, A., Hunot, S., Michel, P.P., Muriel, M.P., Vyas, S., Faucheux, B.A., Mouatt-Prigent, A., Tunnel, H., Srinivasan, A., Ruberg, M., Evan, G.I., Agid, Y. & Hirsch, E.C. (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Natl Acad. Sci. USA, 97, 2875-2880.
21. Hartmann, A., Troadec, J.D., Hunot, S., Kikly, K., Faucheux, B.A., Mouatt-Prigent, A., Ruberg, M., Agid, Y. & Hirsch, E.C. (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci., 21, 2247-2255.
22. Hirsch, B.C., Hunot, S., Damier, P. & Faucheux, B. (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol., 44, S115-S120.
23. Hirsch, E.C., Hunot, S., Faucheux, B., Agid, Y., Mizuno, Y., Mochizuki, H., Tatton, W.G., Tatton, N. & Olanow, W.C. (1999) Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov. Disord., 14, 383-385.
24. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. & Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell, 105, 891-902.
25. Imai, Y., Soda, M. & Takahashi, R. (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 275, 35661-35664.
26. Itier, J.-M., Ibanez, P., Mena, M.A., Abbas, N., Cohen-Salmon, C., Bohme, G.A., Laville, M., Pratt, J., Corti, O., Pradier, L., Ret, G., Joubert, C., Periquet, M., Araujo, F., Negroni, J., Casarejos, M.J., Canals, S., Solano, R., Serrano, A., Gallego, E., Sanchez, M., Denefle, P., Benavides, J., Tremp, G., Rooney, T.A., Brice, A. & Garcia de Febenes, S. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum. Mol. Genet., 12, 2277-2291.
27. Jenner, P., Dexter, D.T., Sian, J., Schapira, A.M. & Marsden, C.D. (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol., 32 (Suppl.), S82-S87.
28. Jenner, P. & Olanow, C.W. (1998) Understanding cell death in Parkinson's disease. Ann. Neurol., 44, S72-S84.
29. Jones, D.C., Gunasekar, P.O., Borowitz, J.L. & Isom, G.E. (2000) Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. J. Neurochem., 74, 2296-2304.
30. Kahns, S., Lykkebo, S., Jakobsen, L.D., Nielsen, M.S. & Jensen, P.H. (2002) Caspase-mediated parkin cleavage in apoptotic cell death. J. Biol. Chem., 277, 15303-15308.
31. Keane, R.W., Srinivasan, A., Foster, L.M., Testa, M.P., Ord, T., Nonner, D., Wang, H.G., Reed, J.C., Bredesen, D.E. & Kayalar, C. (1997) Activation of CPP32 during apoptosis of neurons and astrocytes. J. Neurosci. Res., 48, 168-180.
32. Le, W., Rowe, D., Xie, W., Ortiz, I., He, Y. & Appel, S.H. (2001) Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J. Neurosci., 21, 8447-8455.
33. Ledesma, M.D., Galvan, C., Hellias, B., Dotti, C. & Jensen, P.H. (2002) Astrocytic but not neuronal increased expression and redistribution of parkin during unfolded protein stress. J. Neurochem., 83, 1431-1440.
34. Leist, M. & Nicotera, P. (1998) Apoptosis versus necrosis: the shape of neuronal cell death. Results Probl. Cell Differ., 24, 105-135.
35. Lopez, E. & Ferrer, I. (2000) Staurosporine- and H-7-induced cell death in SH-SY5Y neuroblastoma cells is associated with caspase-2 and caspase-3 activation, but not with activation of the FAS/FAS-L-caspase-8 signaling pathway. Brain Res. Mol. Brain Res., 85, 61-67.
36. Luo, Y., Umegaki, H., Wang, X., Abe, R. & Roth, G.S. (1998) Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J. Biol. Chem., 273, 3756-3764.
37. Mena, M.A., de Bernardo, S., Casarejos, M.J., Canals, S. & Rodriguez-Martin, E. (2002) The role of astroglia on the survival of dopamine neurons. Mol. Neurobiol., 25, 245-263.
38. Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H. & Nagatsu, T. (2000) Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J. Neural Transm., 107, 335-341.
39. Moore, J.D., Rothwell, N.J. & Gibson, R.M. (2002) Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent. Br. J. Pharmacol., 135, 1069-1077.
40. Muqit, M.M.K., Davidson, S.M., Payne Smith, M.D., MacCormac, L.P., Kahns, S., Jensen, P.H., Wood, N.W. & Latchman, D.S. (2004) Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival. Hum. Mol. Genet., 13, 117-135.
41. Nicotera, P., Ankarcrona, M., Bonfoco, E., Orrenius, S. & Lipton, S.A. (1997) Neuronal necrosis and apoptosis: two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol., 72, 95-101.
42. Nicotera, P., Leist, M. & Ferrando-May, E. (1999) Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp., 66, 69-73.
43. Olanow, C.W. & Tatton, W.G. (1999) Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci., 22, 123-144.
44. Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J. & Shen, J. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem., 279, 18614-18622.
45. Pan, Y. & Chen, J. (2003) MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell Biol., 23, 5113-5121.
46. Petrucelli, L., O'Farrell, C., Lockhart, P.J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J. & Cookson, M.R. (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron, 36, 1007-1019.
47. Ratan, R.R. & Baraban, J.M. (1995) Apoptotic death in an in vitro model of neuronal oxidative stress. Clin. Exp. Pharmacol. Physiol., 22, 309-310.
48. Rubin, L.L. (1997) Neuronal cell death: when, why and how. Br. Med., 53, 617-631.
49. Schulz, J.B., Lindenau, J., Seyfried, J. & Dichgans, J. (2000) Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem., 267, 4904-4911.
50. Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. & Suzuki, T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 25, 302-305.
51. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. & Selkoe, D.J. (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science, 293, 263-269.
52. Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. & Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron, 37, 735-749.
53. Takuma, K., Baba, A. & Matsuda, T. (2004) Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol., 72, 111-127.
54. Tanaka, K., Suzuki, T., Chiba, T., Shimura, H., Hattori, N. & Mizuno, Y. (2001) Parkin is linked to the ubiquitin pathway. J. Mol. Med., 79, 482-494.
55. Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M.K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvil, S., Cortelli, P., Gilks, W.P., Latchman, D.S., Harvey, R.J., Dallapiccola, B., Auburger, G. & Wood, N.W. (2004) Hereditary early onset Parkinson's disease is caused by mutations in PINK1. Science, 304, 1158-1160. doi:10.1126/science. 1096284.
56. Weingarten, P., Bermak, J. & Zhou, Q.Y. (2001) Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants. J. Neurochem., 76, 1794-1804.
57. Weingarten, P. & Zhou, Q.Y. (2001) Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors. J. Neurochem., 77, 776-785.
58. Yang, Y., Nishimura, I., Imai, Y., Takahashi, R. & Lu, B. (2003) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron, 37, 911-924.
59. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. & Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein CDCrel-1. Proc. Natl Acad. Sci. USA, 97, 13354-13359.